KOVERA LABS · CLIENT RECORD·SNAPSHOT 2026-08-02
Snap Peptides: 10 Kovera certificates.
The lab's record shows 10 certificates printed for Snap Peptides, analysed between 31 Mar 2026 and 2 May 2026, covering 10 products. Median HPLC purity is 99.87%. Kovera graded 10 as a pass and 0 as a fail.
10
certificates
99.87%
median purity
10
products
0
lab verdict: fail
0
failure rules met
What the record shows
RETRIEVED 2 AUGUST 2026None of the 10 certificates meets our failure rules: no lab fail, no unconfirmed identity, no purity under 95% and no content under 90% of the label. 6 measured more than 110% of the label, which Kovera does not grade as a fail.
A certificate covers the sample the client sent, and the client decides which results go public. The figures are as published on 2 August 2026; check the lab's verify page for the current version before you rely on one.
Products tested
10 AS PRINTEDBPC-157 · 1Cagrilintide · 1CJC-1295 (No DAC)/Ipamorelin · 1GHK-Cu · 1Klow · 1NAD+ · 1Retatrutide · 1SS-31 · 1Tesamorelin · 1Tirzepatide · 1
Every certificate
NEWEST FIRST · 10 ROWS| Report | Product | Lot | Purity | % of label | Analysed | Result | Check |
|---|---|---|---|---|---|---|---|
| KVR-2026-7F7618 | Klow | SP26-KLOW80-01 | 99.468% | 104.9%83.89 of 80 mg | 2 May 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-52ACB6 | CJC-1295 (No DAC)/Ipamorelin | SP26-CJCIPA10-01 | 99.196% | 119.0%11.9 of 10 mg | 2 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-1D4A0C | Retatrutide | SP26-RETA30-03 | 99.438% | 114.4%34.33 of 30 mg | 2 May 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-AA9FB6 | GHK-Cu | SP26-GHKCU50-02 | 99.918% | 108.2%54.11 of 50 mg | 21 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-D0106A | Cagrilintide | SP26-CAG5-01 | 99.829% | 115.4%5.77 of 5 mg | 20 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-4827C9 | BPC-157 | SP26-BPC15710-02 | 99.967% | 109.8%10.98 of 10 mg | 20 Apr 2026 | PASS | Kovera ↗our verifier → |
| KVR-2026-0F92A1 | Tirzepatide | SP26-TIRZ30-02 | 99.813% | 112.2%33.67 of 30 mg | 20 Apr 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-E5F3AC | SS-31 | SP26-SS3110-01 | 99.961% | 113.8%11.38 of 10 mg | 31 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-9089C9 | Tesamorelin | SP26-TESA10-02 | 99.948% | 117.4%11.74 of 10 mg | 31 Mar 2026 | PASSover 110% of label | Kovera ↗our verifier → |
| KVR-2026-818468 | NAD+ | SP26-NAD500-01 | 99.987% | 106.3%531.66 of 500 mg | 31 Mar 2026 | PASS | Kovera ↗our verifier → |